321 related articles for article (PubMed ID: 21162552)
1. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules.
Kim TW; Slowing II; Chung PW; Lin VS
ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552
[TBL] [Abstract][Full Text] [Related]
2. Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells.
Kim TW; Chung PW; Slowing II; Tsunoda M; Yeung ES; Lin VS
Nano Lett; 2008 Nov; 8(11):3724-7. PubMed ID: 18954128
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
[TBL] [Abstract][Full Text] [Related]
4. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
5. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids.
Muhammad F; Guo M; Qi W; Sun F; Wang A; Guo Y; Zhu G
J Am Chem Soc; 2011 Jun; 133(23):8778-81. PubMed ID: 21574653
[TBL] [Abstract][Full Text] [Related]
6. Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.
Mortera R; Vivero-Escoto J; Slowing II; Garrone E; Onida B; Lin VS
Chem Commun (Camb); 2009 Jun; (22):3219-21. PubMed ID: 19587919
[TBL] [Abstract][Full Text] [Related]
7. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer.
Zhang P; Wu T; Kong JL
ACS Appl Mater Interfaces; 2014 Oct; 6(20):17446-53. PubMed ID: 25231082
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
9. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
10. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
[TBL] [Abstract][Full Text] [Related]
11. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
[TBL] [Abstract][Full Text] [Related]
12. A pH gated, glucose-sensitive nanoparticle based on worm-like mesoporous silica for controlled insulin release.
Sun L; Zhang X; Zheng C; Wu Z; Li C
J Phys Chem B; 2013 Apr; 117(14):3852-60. PubMed ID: 23517533
[TBL] [Abstract][Full Text] [Related]
13. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
Lu F; Wu SH; Hung Y; Mou CY
Small; 2009 Jun; 5(12):1408-13. PubMed ID: 19296554
[No Abstract] [Full Text] [Related]
14. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins.
Slowing II; Trewyn BG; Lin VS
J Am Chem Soc; 2007 Jul; 129(28):8845-9. PubMed ID: 17589996
[TBL] [Abstract][Full Text] [Related]
15. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pH-Triggered, Targeted Drug Delivery to Cancer Cells by Multifunctional Envelope-Type Mesoporous Silica Nanocontainers.
Yang K; Luo H; Zeng M; Jiang Y; Li J; Fu X
ACS Appl Mater Interfaces; 2015 Aug; 7(31):17399-407. PubMed ID: 26196506
[TBL] [Abstract][Full Text] [Related]
17. Functionalized mesoporous silica particles for application in drug delivery system.
Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid oligosaccharide modified redox-responsive mesoporous silica nanoparticles for targeted drug delivery.
Zhao Q; Geng H; Wang Y; Gao Y; Huang J; Wang Y; Zhang J; Wang S
ACS Appl Mater Interfaces; 2014 Nov; 6(22):20290-9. PubMed ID: 25311422
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Phenylboronic-Acid-Capped ZnS Nanocrystals Designed As Caps in Mesoporous Silica Hybrid Materials for on-Demand pH-Triggered Release In Cancer Cells.
Salinas Y; Hoerhager C; García-Fernández A; Resmini M; Sancenón F; Matínez-Máñez R; Brueggemann O
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34029-34038. PubMed ID: 30272435
[TBL] [Abstract][Full Text] [Related]
20. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]